290 related articles for article (PubMed ID: 11020393)
1. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
Peterson JG; Topol EJ; Sapp SK; Young JB; Lincoff AM; Lauer MS
Am J Med; 2000 Oct; 109(5):371-7. PubMed ID: 11020393
[TBL] [Abstract][Full Text] [Related]
2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.
Kleiman NS; Lincoff AM; Kereiakes DJ; Miller DP; Aguirre FV; Anderson KM; Weisman HF; Califf RM; Topol EJ
Circulation; 1998 May; 97(19):1912-20. PubMed ID: 9609084
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
Leor J; Reicher-Reiss H; Goldbourt U; Boyko V; Gottlieb S; Battler A; Behar S
J Am Coll Cardiol; 1999 Jun; 33(7):1920-5. PubMed ID: 10362194
[TBL] [Abstract][Full Text] [Related]
5. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Lincoff AM; Tcheng JE; Califf RM; Kereiakes DJ; Kelly TA; Timmis GC; Kleiman NS; Booth JE; Balog C; Cabot CF; Anderson KM; Weisman HF; Topol EJ
Circulation; 1999 Apr; 99(15):1951-8. PubMed ID: 10208997
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization.
Ibbotson T; McGavin JK; Goa KL
Am J Cardiovasc Drugs; 2003; 3(5):381-6. PubMed ID: 14728074
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
Teo KK; Yusuf S; Pfeffer M; Torp-Pedersen C; Kober L; Hall A; Pogue J; Latini R; Collins R;
Lancet; 2002 Oct; 360(9339):1037-43. PubMed ID: 12383982
[TBL] [Abstract][Full Text] [Related]
8. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
Barron HV; Michaels AD; Maynard C; Every NR
J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
[TBL] [Abstract][Full Text] [Related]
9. Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).
Borghi C; Ambrosioni E; Novo S; Vinereanu D; Ambrosio G;
Clin Cardiol; 2012; 35(7):416-23. PubMed ID: 22707187
[TBL] [Abstract][Full Text] [Related]
10. Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.
Harjai KJ; Solis S; Prasad A; Loupe J
Int J Cardiol; 2003 Apr; 88(2-3):207-14. PubMed ID: 12714200
[TBL] [Abstract][Full Text] [Related]
11. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.
Ibbotson T; McGavin JK; Goa KL
Drugs; 2003; 63(11):1121-63. PubMed ID: 12749745
[TBL] [Abstract][Full Text] [Related]
12. Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.
Ghaffari S; Kereiakes DJ; Lincoff AM; Kelly TA; Timmis GC; Kleiman NS; Ferguson JJ; Miller DP; Califf RA; Topol EJ
Am J Cardiol; 1998 Jul; 82(1):7-12. PubMed ID: 9671000
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
Young JB
Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
[TBL] [Abstract][Full Text] [Related]
14. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
[TBL] [Abstract][Full Text] [Related]
15. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L;
Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
Al-Khadra AS; Salem DN; Rand WM; Udelson JE; Smith JJ; Konstam MA
J Am Coll Cardiol; 1998 Feb; 31(2):419-25. PubMed ID: 9462588
[TBL] [Abstract][Full Text] [Related]
18. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Adgey AA
Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
Shlipak MG; Browner WS; Noguchi H; Massie B; Frances CD; McClellan M
Am J Med; 2001 Apr; 110(6):425-33. PubMed ID: 11331052
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
Braunwald E; Domanski MJ; Fowler SE; Geller NL; Gersh BJ; Hsia J; Pfeffer MA; Rice MM; Rosenberg YD; Rouleau JL;
N Engl J Med; 2004 Nov; 351(20):2058-68. PubMed ID: 15531767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
